Literature DB >> 1999124

Introduction of antibody into viable cells using electroporation.

D L Berglund1, J R Starkey.   

Abstract

Conditions for labelling an intracellular antigen, p21ras, using electroporation to introduce a fluorescent antibody, are described. Following labelling, cells were evaluated for p21ras associated fluorescence by flow cytometry. Electroporation, sorting, and cell handling parameters were varied to determine optimal conditions for cell viability. Cells were best held in serum containing growth medium both before and after electroporation, while antibody introduction during the electroporation phase was most efficient when carried out in a balanced saline solution. For maximum efficiency of antibody internalization, the antibody needed to be present during electroporation, and medium needed to be replaced several times in the first few hours after electroporation to ensure good cell survival.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1999124     DOI: 10.1002/cyto.990120109

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  4 in total

1.  Electroporation: an arsenal of application.

Authors:  Ti-Fei Yuan
Journal:  Cytotechnology       Date:  2007-06-16       Impact factor: 2.058

2.  Quantitative study of molecular transport due to electroporation: uptake of bovine serum albumin by erythrocyte ghosts.

Authors:  M R Prausnitz; C D Milano; J A Gimm; R Langer; J C Weaver
Journal:  Biophys J       Date:  1994-05       Impact factor: 4.033

Review 3.  Applying Antibodies Inside Cells: Principles and Recent Advances in Neurobiology, Virology and Oncology.

Authors:  Congcong Zhang; Rina M Ötjengerdes; Julian Roewe; Rebeca Mejias; Andrea L J Marschall
Journal:  BioDrugs       Date:  2020-08       Impact factor: 5.807

4.  Targeting endogenous nuclear antigens by electrotransfer of monoclonal antibodies in living cells.

Authors:  Guillaume Freund; Annie-Paule Sibler; Dominique Desplancq; Mustapha Oulad-Abdelghani; Marc Vigneron; Julian Gannon; Marc H Van Regenmortel; Etienne Weiss
Journal:  MAbs       Date:  2013-05-29       Impact factor: 5.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.